Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1976 1
1981 3
1982 7
1983 3
1984 2
1985 4
1986 4
1987 3
1988 4
1989 5
1990 3
1991 7
1992 7
1993 14
1994 9
1995 13
1996 21
1997 18
1998 13
1999 15
2000 27
2001 17
2002 32
2003 38
2004 44
2005 36
2006 53
2007 59
2008 61
2009 59
2010 58
2011 56
2012 48
2013 41
2014 46
2015 45
2016 45
2017 44
2018 59
2019 57
2020 56
2021 43
2022 49
2023 3
Text availability
Article attribute
Article type
Publication date

Search Results

1,092 results
Results by year
Filters applied: . Clear all
Page 1
Major depressive disorder.
Otte C, Gold SM, Penninx BW, Pariante CM, Etkin A, Fava M, Mohr DC, Schatzberg AF. Otte C, et al. Among authors: fava m. Nat Rev Dis Primers. 2016 Sep 15;2:16065. doi: 10.1038/nrdp.2016.65. Nat Rev Dis Primers. 2016. PMID: 27629598 Review.
From depression to anxiety, and back.
Bui E, Fava M. Bui E, et al. Among authors: fava m. Acta Psychiatr Scand. 2017 Oct;136(4):341-342. doi: 10.1111/acps.12801. Epub 2017 Sep 2. Acta Psychiatr Scand. 2017. PMID: 28865404 No abstract available.
Bioactive lipids, inflammation and chronic diseases.
Leuti A, Fazio D, Fava M, Piccoli A, Oddi S, Maccarrone M. Leuti A, et al. Among authors: fava m. Adv Drug Deliv Rev. 2020;159:133-169. doi: 10.1016/j.addr.2020.06.028. Epub 2020 Jul 3. Adv Drug Deliv Rev. 2020. PMID: 32628989 Review.
Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1).
Fedgchin M, Trivedi M, Daly EJ, Melkote R, Lane R, Lim P, Vitagliano D, Blier P, Fava M, Liebowitz M, Ravindran A, Gaillard R, Ameele HVD, Preskorn S, Manji H, Hough D, Drevets WC, Singh JB. Fedgchin M, et al. Among authors: fava m. Int J Neuropsychopharmacol. 2019 Oct 1;22(10):616-630. doi: 10.1093/ijnp/pyz039. Int J Neuropsychopharmacol. 2019. PMID: 31290965 Free PMC article. Clinical Trial.
Guidelines for the recognition and management of mixed depression.
Stahl SM, Morrissette DA, Faedda G, Fava M, Goldberg JF, Keck PE, Lee Y, Malhi G, Marangoni C, McElroy SL, Ostacher M, Rosenblat JD, Solé E, Suppes T, Takeshima M, Thase ME, Vieta E, Young A, Zimmerman M, McIntyre RS. Stahl SM, et al. Among authors: fava m. CNS Spectr. 2017 Apr;22(2):203-219. doi: 10.1017/S1092852917000165. Epub 2017 Feb 28. CNS Spectr. 2017. PMID: 28421980 Review.
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD).
Fava M, Freeman MP, Flynn M, Judge H, Hoeppner BB, Cusin C, Ionescu DF, Mathew SJ, Chang LC, Iosifescu DV, Murrough J, Debattista C, Schatzberg AF, Trivedi MH, Jha MK, Sanacora G, Wilkinson ST, Papakostas GI. Fava M, et al. Mol Psychiatry. 2020 Jul;25(7):1592-1603. doi: 10.1038/s41380-018-0256-5. Epub 2018 Oct 3. Mol Psychiatry. 2020. PMID: 30283029 Free PMC article.
1,092 results